Xylem
1,130 hedge funds and large institutions have $75.7B invested in Xylem in 2025 Q4 according to their latest regulatory filings, with 141 funds opening new positions, 411 increasing their positions, 374 reducing their positions, and 74 closing their positions.
136% more capital invested
Capital invested by funds: $32.1B → $75.7B (+$43.6B)
91% more first-time investments, than exits
New positions opened: 141 | Existing positions closed: 74
72% more call options, than puts
Call options by funds: $35.4M | Put options by funds: $20.6M
20.61% more ownership
Funds ownership: 89.4% → 110.01% (+21%)
4% more funds holding
Funds holding: 1,083 → 1,130 (+47)
10% more repeat investments, than reductions
Existing positions increased: 411 | Existing positions reduced: 374
8% less funds holding in top 10
Funds holding in top 10: 13 → 12 (-1)
Top Buyers
| 1 |
JSC
J. Stern & Co
London,
United Kingdom
|
+$6.48B |
| 2 |
BNP Paribas Asset Management
Paris,
France
|
+$130M |
| 3 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
+$122M |
| 4 |
BlackRock
New York
|
+$66.8M |
| 5 |
Jennison Associates
New York
|
+$64.5M |
Top Sellers
XYL Hedge Fund Activity: Q4 2025 in Review
1,130 of the 8,223 institutional investors tracked by Wall St. Rank reported a position in Xylem (XYL) for Q4 2025, worth a combined $75.7B — up 136% from $32.1B a quarter earlier.
Buyers outnumbered sellers: 141 funds opened new XYL positions and 74 closed out — a net gain of 67 holders — while 411 added to existing stakes and 374 trimmed.
The largest buyer was J. Stern & Co, adding an estimated $6.48B. The largest seller was T. Rowe Price Associates, cutting an estimated $109M.
- 1,130 institutional investors held Xylem (XYL) as of Q4 2025, up from 1,083 in Q3 2025.
- Funds reported $75.7B of Xylem stock for Q4 2025, up 136% quarter-over-quarter.
- 141 funds opened new Xylem positions in Q4 2025 and 74 closed out, a net change of +67 holders.
- The largest Xylem buyer in Q4 2025 was J. Stern & Co, an estimated $6.48B added.
- The largest Xylem seller in Q4 2025 was T. Rowe Price Associates, an estimated $109M sold.
Based on aggregated 13F filings for Q4 2025.